Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease

Proton pump inhibitors (PPIs) have been the first line treatment for gastroesophageal reflux disease (GERD). The aim of this study was to evaluate the efficacy of vonoprazan (VPZ), a potassium-competitive acid blocker for reflux esophagitis (RE), nonerosive reflux disease (NERD), and PPI-resistant G...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore)
Hauptverfasser: Gotoh, Yasuhiko, Ishibashi, Emiko, Honda, Shunichiro, Nakaya, Tomohisa, Noguchi, Chishio, Kagawa, Koichi, Murakami, Kazunari
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wolters Kluwer Health 2020
Schlagworte:
4500
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440130/
https://ncbi.nlm.nih.gov/pubmed/32176102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019520
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge